200 related articles for article (PubMed ID: 17606808)
1. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
[TBL] [Abstract][Full Text] [Related]
2. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
[TBL] [Abstract][Full Text] [Related]
3. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
[TBL] [Abstract][Full Text] [Related]
4. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
[TBL] [Abstract][Full Text] [Related]
7. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
[TBL] [Abstract][Full Text] [Related]
8. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
[TBL] [Abstract][Full Text] [Related]
10. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
[TBL] [Abstract][Full Text] [Related]
11. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
[TBL] [Abstract][Full Text] [Related]
12. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
[TBL] [Abstract][Full Text] [Related]
13. Mavacamten decreases maximal force and Ca
Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
[TBL] [Abstract][Full Text] [Related]
14. The effect of myosin regulatory light chain phosphorylation on the frequency-dependent regulation of cardiac function.
Dias FA; Walker LA; Arteaga GM; Walker JS; Vijayan K; Peña JR; Ke Y; Fogaca RT; Sanbe A; Robbins J; Wolska BM
J Mol Cell Cardiol; 2006 Aug; 41(2):330-9. PubMed ID: 16806259
[TBL] [Abstract][Full Text] [Related]
15. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
16. Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin.
Mettikolla P; Calander N; Luchowski R; Gryczynski I; Gryczynski Z; Zhao J; Szczesna-Cordary D; Borejdo J
J Theor Biol; 2011 Sep; 284(1):71-81. PubMed ID: 21723297
[TBL] [Abstract][Full Text] [Related]
17. The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts.
Muthu P; Kazmierczak K; Jones M; Szczesna-Cordary D
J Cell Mol Med; 2012 Apr; 16(4):911-9. PubMed ID: 21696541
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
[TBL] [Abstract][Full Text] [Related]
19. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
[TBL] [Abstract][Full Text] [Related]
20. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
